Rankings
▼
Calendar
RNA Q2 2025 Earnings — Avidity Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
RNA
Avidity Biosciences, Inc.
$2B
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$4M
+88.1% YoY
Gross Profit
-$134M
-3490.5% margin
Operating Income
-$171M
-4448.7% margin
Net Income
-$157M
-4089.3% margin
EPS (Diluted)
$-1.21
QoQ Revenue Growth
+144.6%
Cash Flow
Operating Cash Flow
-$200M
Free Cash Flow
-$203M
Stock-Based Comp.
$18M
Balance Sheet
Total Assets
$1.4B
Total Liabilities
$176M
Stockholders' Equity
$1.2B
Cash & Equivalents
$244M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$4M
$2M
+88.1%
Gross Profit
-$134M
$1M
-9987.9%
Operating Income
-$171M
-$83M
-107.1%
Net Income
-$157M
-$71M
-122.2%
Revenue Segments
Reportable Segment
$4M
100%
← FY 2025
All Quarters
Q3 2025 →